Literature DB >> 1457580

No evidence for neoantigens in human plasma after photochemical virus inactivation.

H Mohr1, J Knüver-Hopf, B Lambrecht, H Scheidecker, H Schmitt.   

Abstract

Photodynamic virus inactivation of human fresh plasma mediated by visible light in the presence of the phenothiazine dyes methylene blue or toluidine blue was investigated to determine whether it influences functional, structural, and immunological properties of plasma proteins. The activities of the coagulation factors I, VIII, IX, X, and XI were affected to a certain degree, while those of most other plasma proteins were not. The elution profiles obtained by ion exchange chromatography of untreated and photodynamically treated plasma were almost identical. Using a number of antisera against human plasma and single plasma proteins, different immunochemical techniques revealed identical patterns for untreated and treated plasma. Thus, there was no indication that the photodynamic virus inactivation procedure applied considerably influences the properties of plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457580     DOI: 10.1007/bf01703949

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  25 in total

1.  Inactivation of viruses by the photodynamic action of toluidine blue.

Authors:  C W HIATT; E KAUFMAN; J J HELPRIN; S BARON
Journal:  J Immunol       Date:  1960-05       Impact factor: 5.422

2.  Photodynamic therapy of viral contaminants with potential for blood banking applications.

Authors:  J L Matthews; J T Newman; F Sogandares-Bernal; M M Judy; H Skiles; J E Leveson; A J Marengo-Rowe; T C Chanh
Journal:  Transfusion       Date:  1988 Jan-Feb       Impact factor: 3.157

3.  A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis.

Authors:  G J Naylor; B Martin; S E Hopwood; Y Watson
Journal:  Biol Psychiatry       Date:  1986-08       Impact factor: 13.382

4.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

5.  Viral inactivation of blood products.

Authors:  J C Fratantoni; K N Prodouz; M S Horowitz
Journal:  Transfusion       Date:  1990 Jul-Aug       Impact factor: 3.157

6.  Quantitative immunoelectrophoresis of human serum proteins.

Authors:  H G Clarke; T Freeman
Journal:  Clin Sci       Date:  1968-10       Impact factor: 6.124

Review 7.  Prevention of infectious disease transmission by blood and blood products.

Authors:  D L Aronson; D Menaché
Journal:  Prog Hematol       Date:  1987

8.  Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus.

Authors:  H J Alter; R P Creagan; P A Morel; G P Wiesehahn; B P Dorman; L Corash; G C Smith; H Popper; J W Eichberg
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

9.  Photodynamic inactivation of herpes simplex virus by hematoporphyrin derivative and light.

Authors:  A A Lewin; L E Schnipper; C S Crumpacker
Journal:  Proc Soc Exp Biol Med       Date:  1980-01

10.  Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products.

Authors:  J M O'Brien; R R Montgomery; W H Burns; D K Gaffney; F Sieber
Journal:  J Lab Clin Med       Date:  1990-10
View more
  5 in total

1.  Photodynamic treatment of pooled coumarin plasma for external quality assessment of the prothrombin time.

Authors:  A M van den Besselaar; A C Moor
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

2.  Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.

Authors:  Jerard Seghatchian; Wilhelm G Struff; Stefan Reichenberg
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

Review 3.  Inactivation of viruses in fresh-frozen plasma.

Authors:  J U Wieding; P Hellstern; M Köhler
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

4.  [Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP].

Authors:  C Naegelen; H Isola; D Dernis; J-P Maurel; R Tardivel; S Bois; C Vignoli; J-P Cazenave
Journal:  Transfus Clin Biol       Date:  2009-05-13       Impact factor: 1.406

5.  Inactivation of dengue virus by methylene blue/narrow bandwidth light system.

Authors:  Qing Huang; Wei-Ling Fu; Bing Chen; Jun-Fu Huang; Xue Zhang; Qiang Xue
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.